REGENXBIO Cost of Revenue | RGNX

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.

What is included in the cost of revenue

Cost Category	Examples
Production Costs	Materials, wages of production staff, depreciation of equipment
Service and Support	Customer service, user support, technical assistance
Delivery and Logistics	Packaging, delivery of goods to customers
Hosting and Infrastructure	Servers, cloud platforms (especially for IT and SaaS companies)
Content and Licenses	License purchases, production royalties (e.g., in streaming services)

Importance of the Metric

Helps to understand how costly the revenue-generating process is.
A high cost of revenue may indicate:
Poor cost control
Low operational efficiency
A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue REGENXBIO

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	33.6 M	37.2 M	54.5 M	51.8 M	35.7 M	8.24 M	9.64 M	1.71 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
54.5 M	1.71 M	29.1 M

Quarterly Cost of Revenue REGENXBIO

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	12.4 M	10.6 M	4.28 M	-	12.4 M	9.48 M	4.11 M	-	13.1 M	13 M	15.7 M	-	14.1 M	9.82 M	4.85 M	-	17.4 M	4.68 M	3.41 M	-	2.49 M	1.93 M	29 K	-	517 K	3.87 M	2.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.4 M	29 K	7.64 M

Cost of Revenue of other stocks in the Biotechnology industry

Issuer	Cost of Revenue	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	62.5 K	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	49.4 M	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	40 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	27.2 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	3.73 M	-	-	$ 2.18 B	USA
ASLAN Pharmaceuticals Limited ASLN	407 K	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	10.6 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	106 M	-	-	$ 867 M	Germany
Abcam plc ABCM	91.2 M	-	-	$ 4.9 B	Britain
Midatech Pharma plc MTP	926 K	-	-18.52 %	$ 27.3 M	Britain
MorphoSys AG MOR	58.4 M	-	2.43 %	$ 254 M	Germany
AnPac Bio-Medical Science Co., Ltd. ANPC	3.71 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	515 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	24.8 M	-	-7.31 %	$ 87 M	USA
Ayala Pharmaceuticals AYLA	602 K	-	-	$ 7.46 M	Israel
Jaguar Health JAGX	3.77 M	$ 0.96	-6.48 %	$ 2.24 M	USA
Johnson & Johnson JNJ	30.3 B	$ 263.4	1.58 %	$ 634 B	USA
Advaxis ADXS	13 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	4.85 M	-	5.93 %	$ 314 M	Canada
Alkermes plc ALKS	196 M	$ 52.89	-0.15 %	$ 8.71 B	Irlanda
AIkido Pharma AIKI	145 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.36 M	-	-0.23 %	$ 916 M	USA